Intra-arterial Recombinant Human TNK Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Large Vascular Occlusion After Successful Mechanical Thrombectomy Recanalization
Clinical trial NCT05624190 · UNKNOWN
Trial details
- NCT number
- NCT05624190
- Sponsor
- Beijing Tiantan Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-16
- Primary completion
- 2024-07-01
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.